Intrust Bank NA Cuts Stake in Fresenius Medical Care AG & Co. (FMS)

Intrust Bank NA decreased its stake in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) by 25.4% during the fourth quarter, HoldingsChannel reports. The firm owned 12,575 shares of the company’s stock after selling 4,290 shares during the quarter. Intrust Bank NA’s holdings in Fresenius Medical Care AG & Co. were worth $661,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in FMS. UBS Asset Management Americas Inc. boosted its stake in Fresenius Medical Care AG & Co. by 3.6% during the second quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock worth $114,000 after acquiring an additional 81 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Fresenius Medical Care AG & Co. by 8.9% during the second quarter. Ameriprise Financial Inc. now owns 12,028 shares of the company’s stock worth $581,000 after acquiring an additional 978 shares in the last quarter. Ferguson Wellman Capital Management Inc. boosted its stake in Fresenius Medical Care AG & Co. by 0.7% during the fourth quarter. Ferguson Wellman Capital Management Inc. now owns 141,236 shares of the company’s stock worth $7,422,000 after acquiring an additional 1,020 shares in the last quarter. D.A. Davidson & CO. boosted its stake in Fresenius Medical Care AG & Co. by 6.8% during the third quarter. D.A. Davidson & CO. now owns 16,854 shares of the company’s stock worth $823,000 after acquiring an additional 1,077 shares in the last quarter. Finally, Comerica Bank boosted its stake in Fresenius Medical Care AG & Co. by 2.4% during the fourth quarter. Comerica Bank now owns 48,984 shares of the company’s stock worth $2,769,000 after acquiring an additional 1,136 shares in the last quarter. 2.57% of the stock is currently owned by hedge funds and other institutional investors.

Fresenius Medical Care AG & Co. (FMS) opened at $54.04 on Thursday. The company has a quick ratio of 0.98, a current ratio of 1.22 and a debt-to-equity ratio of 0.55. The stock has a market cap of $32,459.39, a PE ratio of 23.75, a price-to-earnings-growth ratio of 2.01 and a beta of 0.52. Fresenius Medical Care AG & Co. has a twelve month low of $40.21 and a twelve month high of $57.94.

Several equities research analysts recently commented on the stock. Zacks Investment Research lowered shares of Fresenius Medical Care AG & Co. from a “buy” rating to a “hold” rating in a research note on Tuesday, January 23rd. SunTrust Banks set a $62.00 price objective on shares of Fresenius Medical Care AG & Co. and gave the stock a “buy” rating in a research note on Thursday, December 21st. Nord/LB reissued a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research note on Tuesday, January 2nd. DZ Bank reissued a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research note on Monday, November 13th. Finally, Morgan Stanley lowered shares of Fresenius Medical Care AG & Co. from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 11th. Six equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $56.00.

COPYRIGHT VIOLATION WARNING: “Intrust Bank NA Cuts Stake in Fresenius Medical Care AG & Co. (FMS)” was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.themarketsdaily.com/2018/02/15/intrust-bank-na-cuts-stake-in-fresenius-medical-care-ag-co-fms.html.

Fresenius Medical Care AG & Co. Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG & Co. (NYSE:FMS).

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply